Revenue from the digital biomarkers market is expected to reach nearly $22 billion by 2030, according to a July 26 report from Prescient and Strategic Intelligence.
The market drew revenue of $1.9 billion in 2021, making the projected compound annual growth rate 31.6 percent through 2030. The report cites the COVID-19 pandemic as a driver of growth in mobile health applications, along with the integration of artificial intelligence into wearable technology and the rise of telemedicine. Data collection makes up over 90 percent of the digital biomarkers market, according to the July 26 report.
The report suggests that cardiac applications are another source of growth within the digital biomarkers market. North America has been the largest market for digital biomarkers technologies.